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In order to promote the use of mushrooms as source of nutrients and nutraceuticals, several experiments
were performed in wild and commercial species. The analysis of nutrients included determination of pro-
teins, fats, ash, and carbohydrates, particularly sugars by HPLC-RI. The analysis of nutraceuticals included
determination of fatty acids by GC-FID, and other phytochemicals such as tocopherols, by HPLC-ﬂuores-
cence, and phenolics, ﬂavonoids, carotenoids and ascorbic acid, by spectrophotometer techniques. The
antimicrobial properties of the mushrooms were also screened against fungi, Gram positive and Gram
negative bacteria. The wild mushroom species proved to be less energetic than the commercial sp., con-
taining higher contents of protein and lower fat concentrations. In general, commercial species seem to
have higher concentrations of sugars, while wild sp. contained lower values of MUFA but also higher con-
tents of PUFA. a-Tocopherol was detected in higher amounts in the wild species, while c-tocopherol was
not found in these species. Wild mushrooms revealed a higher content of phenols but a lower content of
ascorbic acid, than commercial mushrooms. There were no differences between the antimicrobial prop-
erties of wild and commercial species. The ongoing research will lead to a new generation of foods, and
will certainly promote their nutritional and medicinal use.
 2008 Elsevier Ltd. All rights reserved.1. Introduction
Anutraceutical can be deﬁned as a substance thatmaybe consid-
ered a food or part of a food and provides medical or health beneﬁts
like the prevention and treatment of disease. Nutraceuticals may
range from isolated nutrients and dietary supplements to geneti-
cally engineered ‘‘designer” foods, herbal products and processed
products such as cereals, soups and beverages. Some examples of
nutritive nutraceuticals or ‘‘functional food ingredients” are dietary
ﬁber, polyunsaturated fatty acids (PUFA, ﬁsh oil), proteins, peptides,
amino acids, keto acids, minerals, antioxidative vitamins and other
antioxidants (glutathione, selenium, etc) (Andlauer and Fürst, 2002;
Kruger andMann, 2003). PUFAs, especially the n-3 fatty acid family,
are claimed to exert a protective effect against the development of
cardiovascular and inﬂammatory diseases (Fürst and Kuhn, 2000;
Fang et al., 2002). Epidemiological studies have consistently shown
an inverse association between consumption of vegetables and
fruits and the risk of cardiovascular diseases (Bazzano et al., 2001)
and certain forms of cancer (Liu, 2003). Although the protective ef-
fects have been primarily attributed to well-known antioxidants,
such as ascorbic acid, tocopherols and b-carotene, plant phenolics
may also play a signiﬁcant role (Soobrattee et al., 2005).
Different mushrooms were studied by the scientiﬁc community,
in searching for new therapeutic alternatives, and the resultsll rights reserved.
: +351 273 325405.proved their bioactive properties (Lindequist et al., 2005). Mush-
rooms are rich sources of nutraceuticals (Çag˘larirmak, 2007;
Elmastas et al., 2007; Ribeiro et al., 2007) responsible for their anti-
oxidant (Mau et al., 2002; Lo and Cheung, 2005; Barros et al.,
2007a), antitumor (Wasser and Weis, 1999), and antimicrobial
properties (Smânia et al., 1995; Hirasawa et al., 1999; Hatvani,
2001; Barros et al., 2007b; Turkoglu et al., 2007). Besides their
pharmacological features (Lindequist et al., 2005), wild mush-
rooms are becoming more important in our diet due to their nutri-
tional value, related to the high protein and low fat/energy
contents (Diéz and Alvarez, 2001; Agahar-Murugkar and Sub-
bulakshmi, 2005; Barros et al., 2007c).
Our research group has been interested in nutritional and bioac-
tive properties of wild mushrooms such as antioxidant activity
(Barros et al. 2007a), antimicrobial activity (Barros et al., 2007b),
and the inﬂuence of conservation treatment/cooking (Barros et
al., 2007d) and fruiting body maturity stage (Barros et al., 2007e)
on these properties.
In the present study we intend to evaluate the composition of
wild and commercial mushrooms in nutrients and nutraceuticals.
The evaluation of nutrient composition included the determination
of proteins, fats, ash, carbohydrates, and individual proﬁle of sug-
ars. The evaluation of nutraceutical composition included the
determination of fatty acids, phenolics, ﬂavonoids, carotenoids,
ascorbic acid and tocopherols. Antimicrobial activity was screened
against fungi, Gram positive and Gram negative bacteria, and cor-
related to the bioactive compounds present in the extracts.
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2.1. Samples
Eight mushrooms species: Boletus edulis Fr., Calocybe gambosa (Fr.) Donk, Can-
tharellus cibarius L. ex Fr., Craterellus cornucopioides Pers., Marasmius oreades (Bolt.
ex Fr.) Fr. were commercial dried samples obtained in several supermarkets. All
the others (Agaricus bisporus (Lange) Imbach, Agaricus silvaticus Schaeff., Agaricus sil-
vicola (Vittad.) Peck were wild species and were collected under grassland in Brag-
anca (Northeast of Portugal), in autumn 2006. The morphological identiﬁcation of
the wild macrofungi was made till species according to macro and microscopic
characteristics, and following several authors (Moser, 1983; Courtecuisse and Du-
hem, 1995) and representative voucher specimens were deposited at the herbarium
of Escola Superior Agrária of Instituto Politécnico de Braganca. After collection and
taxonomic identiﬁcation, those mushrooms were lyophilized (Ly-8-FM-ULE, Snij-
ders, HOLLAND) before analysis.
2.2. Standards and reagents
Acetonitrile 99.9%, n-hexane 95% and ethyl acetate 99.8% were of HPLC grade
from Lab-Scan (Lisbon, Portugal). All the other reagents were of analytical grade
purity: methanol and diethyl ether were supplied by Lab-Scan (Lisbon, Portugal);
toluene from Riedel-de-Haën; sulphuric acid from Fluka (St. Gallen, Switzerland).
The fatty acids methyl ester (FAME) reference standard mixture 37 (fatty acids
C4–C24; (standard 47885-U) was from Supelco (Bellefonte, PA, USA) and purchased
from Sigma (St. Louis, MO, USA), as also other individual fatty acid isomers, tocoph-
erol standards (a, b, c and d), and the standards gallic acid and (+)-catechin. The
standards used in the antimicrobial activity assays, ampicillin and cycloheximide,
as also butylated hydroxytoluene (BHT) were purchased from Merck (Darmstadt,
Germany). All other chemicals were obtained from Sigma Chemical Co. (St. Louis,
MO, USA). Water was treated in a Mili-Q water puriﬁcation system (TGI Pure Water
Systems, USA).2.3. Nutrient composition
2.3.1. Nutritional value
Samples of mushrooms were analysed for chemical composition (protein, fat,
carbohydrates and ash) using the AOAC procedures (1995). The crude protein con-
tent (N  4.38) of the samples was estimated by the macroKjeldahl method; the
crude fat was determined by extracting a known weight of powdered mushroom
sample with petroleum ether, using a Soxhlet apparatus; the ash content was deter-
mined by incineration at 600 ± 15 C; reducing sugars were determined by DNS
(dinitrosalicylic acid) method. Total carbohydrates were calculated by difference:
Total carbohydrates = 100 – (g moisture + g protein + g fat + g ash). Total energy
was calculated according to the following equations: Energy (kJ) = 17  (g pro-
tein + g carbohydrate) + 37  (g lipid).
2.3.2. Sugar composition
Free sugars were determined by high performance liquid chromatography cou-
pled to a refraction index detector (HPLC-RI) based on the method used by Harada
et al. (2004) with minor modiﬁcations. Dried powder (1.0 g) was extracted with
40 ml of 80% aqueous ethanol at 80 C for 30 min. The resulting suspension was
centrifuged at 15,000g for 10 min. The supernatant was concentrated at 60 C under
reduced pressure and defatted three times with 10 ml of ethyl ether, successively.
After concentration at 40 C, the solid residues were dissolved in water to a ﬁnal
volume of 5 ml. Soluble sugars were determined by using HPLC (Knauer, Smartline
system) at 35 C. The HPLC system was equipped with a Knauer Smartline 2300 RI
detector and with a Eurospher 100-5 NH2 column (4.6  250 mm, 5 mm, Knauer).
The mobile phase was acetonitrile/deionized water, 7:3 (v/v) at a ﬂow rate of
1.25 ml/min. The results are expressed in g/100 g of dry weight, calculated by inter-
nal normalization of the chromatographic peak area. Sugar identiﬁcation was made
by comparing the relative retention times of sample peaks with standards. The su-
gar standards used for identiﬁcation were purchased from Sigma Chemical Co. (St.
Louis, USA): L(+)-arabinose, D()-fructose, D(+)-galactose, D(+)-glucose anhydrous,
lactose 1-hydrate, maltose 1-hydrate, D(+)-mannitol, D(+)-mannose, D(+)-melezi-
tose, D(+)-melibiose monohydrate, L(+)-rhamnose monohydrate, D(+)-sucrose,
D(+)-trehalose and D(+)-xylose.
2.4. Nutraceutical composition
2.4.1. Fatty acid composition
Fatty acids were determined by gas-liquid chromatography with ﬂame ioniza-
tion detection (GLC-FID)/capillary column based on the following trans-esteriﬁca-
tion procedure: fatty acids were methylated with 5 mL of methanol:sulphuric
acid:toluene 2:1:1 (v:v), during at least 12 h in a bath at 50 C and 160 rpm; then
5 mL of deionised water were added, to obtain phase separation; the FAME wererecovered with 5 mL of diethyl ether by shaking in vortex, and the upper phase
was passed through a micro-column of sodium sulphate anhydrous, in order to
eliminate the water; the sample was recovered in a vial with Teﬂon, and before
injection the sample was ﬁltered with 0.2 lm nylon ﬁlter from Milipore. The fatty
acid proﬁle was analyzed with a DANI model GC 1000 instrument equipped with
a split/splitless injector, a ﬂame ionization detector (FID) and a Macherey-Nagel col-
umn (30 m  0.32 mm ID  0.25 lm df). The oven temperature program was as fol-
lows: the initial temperature of the column was 50 C, held for 2 min, then a 10 C/
min ramp to 240 C and held for 11 min. The carrier gas (hydrogen) ﬂow-rate was
4.0 mL/min (0.61 bar), measured at 50 C. Split injection (1:40) was carried out at
250 C. For each analysis 1 lL of the sample was injected in GC. Fatty acid identiﬁ-
cation was made by comparing the relative retention times from samples with
FAME peaks (standards). The results were recorded and processed using CSW 1.7
software (DataApex 1.7) and expressed in relative percentage of each fatty acid.2.4.2. Tocopherol composition
BHT solution in hexane (10 mg/mL; 100 lL) and IS solution in hexane (d-
tocopherol; 1.6 lg/mL; 250 lL) were added to the sample prior to the extraction
procedure. The samples (500 mg) were homogenized with methanol (4 mL) by
vortex mixing (1 min). Subsequently, hexane (4 mL) was added and again vortex
mixed for 1 min. After that, saturated NaCl aqueous solution (2 mL) was added,
the mixture was homogenized (1 min), centrifuged (5 min, 4000g) and the clear
upper layer was carefully transferred to a vial. The sample was re-extracted twice
with hexane. The combined extracts were taken to dryness under a nitrogen
stream, redissolved in 1 mL of n-hexane, dehydrated with anhydrous sodium sul-
phate, ﬁltered through a 0.22 lm disposable LC ﬁlter disk, transferred into a dark
injection vial and analysed by HPLC. The HPLC equipment consisted of an inte-
grated system with a Smartline pump 1000 (Knauer, Germany), a degasser system
Smartline manager 5000, an AS-2057 auto-sampler and a 2500 UV detector at
295 nm (Knauer, Germany) connected in series with a FP-2020 ﬂuorescence detec-
tor (Jasco, Japan) programmed for excitation at 290 nm and emission at 330 nm.
Data were analysed using Clarity 2.4 Software (DataApex). The chromatographic
separation was achieved with a Polyamide II (250  4.6 mm) normal-phase column
from YMCWaters (Japan) operating at 30 C (7971 R Grace oven). The mobile phase
used was a mixture of n-hexane and ethyl acetate (70:30, v/v) at a ﬂow rate of
1 mL/min, and the injection volume was 20 lL. The compounds were identiﬁed
by chromatographic comparisons with authentic standards. Quantiﬁcation was
based on the ﬂuorescence signal response, using the internal standard method.
Tocopherol contents in mushroom samples are expressed in lg per g of dry
mushroom.
2.4.3. Total bioactive compounds
Bioactive compounds were determined after methanolic extraction of the sam-
ples. Phenols, ﬂavonoids, ascorbic acid and carotenoids were determined according
to procedures previously described by us (Barros et al., 2007e). For phenolic com-
pound determination in the mushroom extracts, 1 mL of sample was mixed with
1 mL of Folin and Ciocalteu’s phenol reagent. After 3 min, 1 mL of saturated sodium
carbonate solution was added to the mixture and adjusted to 10 mL with distilled
water. The reaction was kept in the dark for 90 min, after which the absorbance
was read at 725 nm (Analytikijena 200-2004 spectrophotometer). Gallic acid was
used to calculate the standard curve (0.01–0.4 mM; Y = 2.8557X-0.0021;
R2 = 0.9999) and the results were expressed as mg of gallic acid equivalents (GAEs)
per g of extract.
For ﬂavonoid contents determination the mushroom extract (250 lL) was
mixed with 1.25 mL of distilled water and 75 lL of a 5% NaNO2 solution. After
5 min, 150 lL of a 10% AlCl3  H2O solution was added. After 6 min, 500 lL of 1 M
NaOH and 275 lL of distilled water were added to the mixture. The solution was
mixed well and the intensity of pink colour was measured at 510 nm. (+)-catechin
was used to calculate the standard curve (0.022–0.34 mM; Y = 0.9629X-0.0002;
R2 = 0.9999) and the results were expressed as mg of (+)-chatequin equivalents
(CEs) per g of extract.
For ascorbic acid determination the dried methanolic extract (100 mg) was ex-
tracted with 10 mL of 1% metaphosphoric acid for 45 min at room temperature and
ﬁltered through Whatman No. 4 ﬁlter paper. The ﬁltrate (1 mL) was mixed with
9 mL of 2,6-dichlorophenolindophenol and the absorbance was measured within
30 min at 515 nm against a blank. Content of ascorbic acid was calculated on the
basis of the calibration curve of authentic L-ascorbic acid (0.020–0.12 mg/mL;
Y = 3.4127X-0.0072; R2 = 0.9905) and the results were expressed as mg of ascorbic
acid/g of extract.
For b-carotene and lycopene determination the dried methanolic extract
(100 mg) was vigorously shaken with 10 mL of acetone–hexane mixture (4:6) for
1 min and ﬁltered through Whatman No. 4 ﬁlter paper. The absorbance of the
ﬁltrate was measured at 453, 505 and 663 nm. Contents of -carotene and lyco-
pene were calculated according to the following equations: lycopene (mg/
100 mL) = 0.0458  A663 + 0.372  A505  0.0806  A453; b-carotene (mg/
100 mL) = 0.216  A663  0.304  A505 + 0.452  A453. The results were
expressed as lg of carotenoid/g of extract.
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The assays were performed in the methanolic extracts after redissolution in
DMSO at a concentration of 50 mg/mL.
2.5.1. Microorganisms and culture conditions
Microorganisms labeled CECT were obtained from the Spanish type culture col-
lection (CECT) of Valencia University, while microorganisms labeled ESA were clin-
ically isolated strains from different biological ﬂuids, identiﬁed by Microbiology
Laboratory of Escola Superior Agrária de Braganca. Gram + (Bacillus cereus CECT
148, B. subtilis CECT 498, Staphylococus aureus ESA 7 isolated from pus) and Gram
– (Escherichia coli CECT 101, Pseudomonas aeruginosa CECT 108, Klebsiella pneumo-
niae ESA 8 isolated from urine) bacteria, and fungi (Candida albicans CECT 1394,
Cryptococcus neoformans ESA 3 isolated from vaginal ﬂuid) were used to screen
samples antimicrobial activity. Microorganisms were cultured aerobically at 37 C
(Scientiﬁc 222 oven model, 2003) in nutrient agar medium for bacteria, and at
30 C (Scientiﬁc 222 oven model, 2003) in sabouraud dextrose agar medium for
fungi.
2.5.2. Test assays for antimicrobial activity
A screening of antibacterial activities against the Gram  and Gram + bacteria
and fungi was performed, and the minimal inhibitory concentration (MIC) was
determined by an adaptation of the agar streak dilution method based on radial dif-
fusion (Barros et al., 2007b). Suspensions of the microorganisms were prepared to
contain approximately 108 cfu/mL, and the plates containing agar medium were
inoculated (100 lL). A 50 lL volume of each sample was placed in a hole (depth
3 mm, diameter 4 mm) made in the centre of the agar. Under the same conditions,
different DMSO solutions of ampicillin (antibacterial) and cycloheximide (anti-
fungal) were used as standards. DMSO was chosen as the best solvent after compar-
ative toxicity assays which proved its non toxicity. The MIC was considered to be
the lowest concentration of the tested sample able to inhibit the growth of bacteria
or fungi, after 24 h. The inhibition halos corresponding to the MICs were measured
using a ruler, with an accuracy of 0.5 mm. Each inhibition halo was measured three
times (three different plates) and the average was considered. A control using only
inoculation was also carried out.
2.6. Statistical analysis
For each one of the mushroom species three samples were analysed and also all
the assays were carried out in triplicate. The results are expressed as mean values
and standard deviation (SD). The results were analyzed using one-way analysis of
variance (ANOVA) followed by Tukey’s HSD Test with a = 0.05, using SAS v. 9.1.3
program.
3. Results
3.1. Nutrient composition
The results of the chemical composition and estimated ener-
getic value (expressed on dry weight basis) of the wild and com-
mercial edible mushrooms are shown in Table 1. Protein was
found in high levels and varied between 17.18 g/100 g in B. edulis
and 80.93 g/100 g in A. bisporus. Fat ranged from 0.92 g/100 g in
A. bisporus and 4.88 g/100 g in C. cornucopioides. In general, wild
mushrooms were richer sources of protein and had a lower amount
of fat than commercial mushrooms. Carbohydrates, calculated by
difference, were also an abundant macronutrient and ranged from
8.25 g/100 g in A. bisporus and 71.15 g/100 g in B. edulis. ReducingTable 1
Proximate chemical composition (g/100 g) and energetic value (kJ/100 g) of wild and com
Specie Total fat Crude protein Ash
Agaricus bisporus 0.92 ± 0.06 d 80.93 ± 3.53 a 9.90 ±
Agaricus silvaticus 2.05 ± 0.01 c 71.99 ± 4.59 b 16.48 ±
Agaricus silvicola 2.43 ± 0.22 cb 70.47 ± 2.01 b 14.93 ±
Boletus edulis 4.60 ± 0.13 a 17.18 ± 0.92 e 7.07 ±
Calocybe gambosa 1.05 ± 0.10 d 47.22 ± 1.32 d 8.72 ±
Cantharellus cibarius 4.49 ± 0.06 a 69.14 ± 3.26 b 12.12 ±
Craterellus cornucopioides 4.88 ± 020 a 69.45 ± 1.24 b 12.22 ±
Marasmius oreades 2.99 ± 0.82 b 52.22 ± 2.57 c 11.39 ±
Results are expressed in a dry weight basis. In each column different letters mean signisugars are only a small part of carbohydrates content, being poly-
saccharides such as chitin and starch the most abundant carbohy-
drates in mushrooms. Ash content varied between 7.07 g/100 g in
B. edulis and 16.48 g/100 g in A. silvaticus. Wild mushroom species
proved to be less energetic providing, on average, 1502 kJ per 100 g
of a dry portion, when compared to the 1597 kJ assured by the
commercial sp. The highest energetic value was obtained for the
commercial B. edulis, while the wild A. silvaticus gave the lowest
energetic contribution (Table 1).
The edible mushrooms contained mannitol and trehalose as the
principal carbohydrates (Table 2). The accumulation of these sug-
ars in the fruit-bodies of other species was already reported (Hara-
da et al., 2004; Barros et al., 2007c). Nevertheless, the present study
also describes the presence of maltose (disaccharide) and melezi-
tose (non-reducing trisaccharide) in some of the studied species.
A. bisporus revealed the highest sugar contents (20.87 g/100 g),
while A. silvaticus revealed the lowest levels (3.72 g/100 g).With
the exception of A. bisporus, the commercial species seem to have
higher concentration of sugars. Otherwise, maltose was not found
in none of the commercial mushrooms. This sugar can be broken
down into two glucose molecules by hydrolysis, and the drying
process to which commercial sp. were submitted could be respon-
sible for the degradation of maltose. Melezitose is obtained
especially from exudations of various trees or from honey made
from such exudations, and therefore incorporated by some
mushrooms.3.2. Nutraceutical composition
The results of fatty acid composition, total saturated fatty
acids (SFA), monounsaturated fatty acids (MUFA), and polyunsatu-
rated fatty acids (PUFA) of the studied mushrooms are shown in
Table 3. In general, the major fatty acid found in the studied species
was linoleic acid (C18:2), followed by oleic acid (C18:1) and
palmitic acid (C16:0). Besides the three main fatty acids already
described, eighteen more were identiﬁed and quantiﬁed. PUFA
were the main group of fatty acids in all species with the exception
of C. cornucopiodes, where MUFA were the main group. Wild Agar-
icus sp. contained a lower value of MUFA but also a higher content
of PUFA than the commercial species, due to the higher contribu-
tion of linoleic acid. The commercial C. gambosa revealed the
highest SFA values, due to the contribution of palmitic acid. Never-
theless, UFA predominated over SFA in all the studied mushrooms,
ranging from 77% to 85%. The commercial B. edulis contained the
highest UFA (85%) and the lowest SFA levels (15%).
Tocopherol contents in the eight studied mushroom, including
three wild (Barros et al., 2008) and ﬁve commercial species is pre-
sented in Table 4. a and b-Tocopherol were found in all species. The
ﬁrst isomer was found in higher amounts in the wild species, while
signiﬁcant differences were not observed in b-tocopherol content
of wild and commercial sp. c-Tocopherol was only found in the
commercial species.mercial mushrooms (mean ± SD; n = 3)
Carbohydrates Reducing sugars Energy
0.05 d 8.25 ± 1.42 d 1.44 ± 0.02 cb 1550.05 ± 21.65 c
0.23 a 9.49 ± 2.84 d 2.36 ± 0.15 cb 1460.87 ± 23.88 e
0.66 b 12.18 ± 2.02 d 2.00 ± 0.08 ed 1494.82 ± 13.89 d
0.59 e 71.15 ± 1.55 a 3.39 ± 0.30 a 1671.83 ± 18.72 a
0.81d 43.01 ± 1.31 b 1.26 ± 0.06 ed 1566.23 ± 11.07 b
0.26 c 14.25 ± 3.96 d 2.54 ± 0.16 cb 1572.87 ± 22.63 cb
0.81 c 13.44 ± 1.85 d 2.70 ± 0.29 b 1583.78 ± 14.28 b
0.09 c 29.41 ± 3.32 c 2.21 ± 0.33 cb 1589.91 ± 12.07 cb
ﬁcant differences (p < 0.05).
Table 2
Sugar composition (g/100 g) of wild and commercial mushrooms (mean ± SD; n = 3)
Mannitol Trehalose Maltose Melezitose Total sugars
Agaricus bisporus 19.57 ± 0.07 a 0.77 ± 0.01 e nd 0.53 ± 0.00 b 20.87 ± 0.07 a
Agaricus silvaticus 2.65 ± 0.02 f 0.25 ± 0.15 fg 0.44 ± 0.02 b 0.38 ± 0.05 cb 3.72 ± 0.10 g
Agaricus silvicola 6.09 ± 0.44 d 0.66 ± 0.07 fe 0.57 ± 0.03 a 0.47 ± 0.01 cb 7.79 ± 0.54 f
Boletus edulis 3.46 ± 0.19 e 9.71 ± 0.19 b nd 0.29 ± 0.01 d 13.46 ± 0.37 c
Calocybe gambosa 0.27 ± 0.00 g 8.01 ± 0.38 c nd 0.85 ± 0.11 a 9.13 ± 0.48 e
Cantharellus cibarius 8.33 ± 0.09 c 6.12 ± 0.10 d nd nd 14.45 ± 0.19 b
Craterellus cornucopioides 10.67 ± 0.20 b 0.11 ± 0.01 g nd nd 10.78 ± 0.21 d
Marasmius oreades 2.42 ± 0.09 f 10.49 ± 0.02 a nd 0.55 ± 0.04 b 13.46 ± 0.03 c
Results are expressed in a dry weight basis. In each column different letters mean signiﬁcant differences (p < 0.05).
nd – not detected.
Table 3
Fatty acid composition (percent) of wild and commercial mushrooms (mean ± SD; n = 3)
A. bisporus A. silvaticus A. silvicola B. edulis C. gambosa C. cibarius C. cornucopioides M. oreades
C6:0 0.03 ± 0.00 0.03 ± 0.00 0.06 ± 0.01 0.02 ± 0.00 0.40 ± 0.07 0.67 ± 0.05 0.04 ± 0.00 0.19 ± 0.02
C8:0 0.03 ± 0.00 0.06 ± 0.00 0.06 ± 0.00 0.08 ± 0.00 0.12 ± 0.03 0.04 ± 0.00 0.13 ± 0.01 0.05 ± 0.01
C10:0 0.05 ± 0.00 0.07 ± 0.00 0.06 ± 0.00 0.01 ± 0.00 0.44 ± 0.04 0.01 ± 0.00 0.07 ± 0.00 0.02 ± 0.00
C12:0 0.05 ± 0.01 0.03 ± 0.00 0.03 ± 0.00 0.03 ± 0.00 0.19 ± 0.01 0.03 ± 0.00 0.07 ± 0.01 0.07 ± 0.00
C14:0 0.49 ± 0.02 0.32 ± 0.01 0.30 ± 0.02 0.15 ± 0.00 0.40 ± 0.03 0.13 ± 0.00 0.07 ± 0.01 0.15 ± 0.04
C15:0 1.03 ± 0.02 0.65 ± 0.01 0.85 ± 0.07 0.21 ± 0.00 0.65 ± 0.06 0.31 ± 0.02 0.22 ± 0.00 0.60 ± 0.03
C16:0 9.97 ± 0.03 11.74 ± 0.08 9.96 ± 0.20 10.03 ± 0.28 15.16 ± 1.34 13.08 ± 0.14 6.66 ± 0.29 13.82 ± 0.26
C16:1 0.14 ± 0.02 0.76 ± 0.01 0.58 ± 0.04 0.53 ± 0.00 0.88 ± 0.08 0.49 ± 0.03 0.18 ± 0.01 1.00 ± 0.09
C17:0 0.68 ± 0.01 0.39 ± 0.00 0.92 ± 0.01 0.15 ± 0.00 0.20 ± 0.02 0.19 ± 0.01 0.13 ± 0.00 0.07 ± 0.02
C18:0 4.08 ± 0.10 1.41 ± 0.00 2.64 ± 0.20 2.75 ± 0.06 2.14 ± 0.27 6.49 ± 0.11 7.83 ± 0.40 1.65 ± 0.22
C18:1n9c 1.30 ± 0.05 6.67 ± 0.01 3.49 ± 0.20 39.72 ± 1.64 18.10 ± 0.68 10.78 ± 0.34 51.85 ± 0.45 28.52 ± 1.72
C18:2n6c 75.72 ± 0.15 74.78 ± 0.01 76.50 ± 0.21 44.32 ± 2.02 57.75 ± 0.98 53.59 ± 0.12 23.67 ± 1.37 50.66 ± 0.63
C18:3n3 0.06 ± 0.00 0.10 ± 0.00 0.05 ± 0.00 0.07 ± 0.01 0.45 ± 0.07 0.08 ± 0.01 0.07 ± 0.01 0.07 ± 0.01
C20:0 2.13 ± 0.01 0.85 ± 0.01 1.77 ± 0.00 0.44 ± 0.02 0.33 ± 0.02 0.31 ± 0.02 0.32 ± 0.02 0.30 ± 0.03
C20:1c 0.07 ± 0.01 0.13 ± 0.00 0.12 ± 0.00 0.49 ± 0.03 nd 11.48 ± 0.02 7.57 ± 0.05 nd
C20:2c 0.21 ± 0.01 0.15 ± 0.00 nd 0.14 ± 0.00 0.12 ± 0.01 0.17 ± 0.00 0.05 ± 0.01 0.20 ± 0.01
C20:3n3+C21:0 0.42 ± 0.03 0.21 ± 0.03 0.36 ± 0.00 0.03 ± 0.00 0.12 ± 0.03 0.23 ± 0.02 nd 0.03 ± 0.00
C22:0 1.62 ± 0.00 0.81 ± 0.03 1.30 ± 0.18 0.30 ± 0.01 0.59 ± 0.05 0.38 ± 0.03 0.35 ± 0.05 0.59 ± 0.05
C23:0 0.37 ± 0.01 0.21 ± 0.03 0.15 ± 0.01 0.04 ± 0.00 0.87 ± 0.06 0.11 ± 0.01 0.05 ± 0.00 0.22 ± 0.02
C24:0 1.56 ± 0.02 0.55 ± 0.03 0.69 ± 0.01 0.31 ± 0.00 0.99 ± 0.03 0.88 ± 0.06 0.43 ± 0.02 1.16 ± 0.08
C24:1 nd 0.11 ± 0.01 0.05 ± 0.00 0.17 ± 0.00 0.07 ± 0.01 0.55 ± 0.04 0.24 ± 0.00 0.65 ± 0.05
SFA 22.08 ± 0.19 a 17.10 ± 0.01 c 18.80 ± 0.46 b 14.52 ± 0.33 d 22.51 ± 0.54 a 22.63 ± 0.24 a 16.36 ± 0.86 c 18.88 ± 0.86 b
MUFA 1.52 ± 0.06 h 7.67 ± 0.02 f 4.25 ± 0.24 g 40.91 ± 1.67 b 19.05 ± 0.58 e 23.29 ± 0.25 d 59.85 ± 0.51 a 30.16 ± 1.39 c
PUFA 76.41 ± 0.13 a 75.23 ± 0.02 a 76.95 ± 0.22 a 44.56 ± 2.01 e 58.42 ± 1.12 b 54.08 ± 0.01 c 23.79 ± 1.37 f 50.96 ± 0.53 d
In each row different letters mean signiﬁcant differences (p < 0.05).
nd – not detected; C – carbon atoms; SFA – saturated fatty acids; MUFA – monounsaturated fatty acids; PUFA – polyunsaturated fatty acids.
Table 4
Tocopherol composition (lg/g) of the wild and commercial mushrooms (mean ± SD; n = 3)
a-tocopherol b-tocopherol c-tocopherol Total
Agaricus bisporusa 0.75 ± 0.04 b 1.66 ± 0.01 b nd 2.41 ± 0.05 cb
Agaricus silvaticusa 0.49 ± 0.03 c 0.68 ± 0.05 c nd 1.16 ± 0.08 ed
Agaricus silvicolaa 1.30 ± 0.01 a 1.93 ± 0.01 b nd 3.23 ± 0.00 b
Boletus edulis 0.32 ± 0.04 d 8.90 ± 0.77 a 1.42 ± 0.07 a 10.65 ± 0.84 a
Calocybe gambosa 0.06 ± 0.00 f 0.20 ± 0.02 c 0.14 ± 0.02 c 0.41 ± 0.01 ef
Cantharellus cibarius 0.12 ± 0.00 f 0.03 ± 0.01 c 0.03 ± 0.00 d 0.18 ± 0.01 f
Craterellus cornucopioides 0.24 ± 0.02 e 1.55 ± 0.05 b 0.08 ± 0.01 dc 1.87 ± 0.02 cd
Marasmius oreades 0.06 ± 0.00 f 0.19 ± 0.09 c 1.30 ± 0.09 b 1.55 ± 0.05 d
In each column different letters mean signiﬁcant differences (p < 0.05).
nd – not detected.
a Barros et al., 2008.
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noids concentrations obtained in the extracts from the wild (Barros
et al., accepted for publication) and commercial mushrooms. Phe-
nols were the major antioxidant component detected in the ex-
tracts (0.88–8.94 mg/g), followed by ﬂavonoids (0.67–3.40 mg/g).
Ascorbic acid was found in small amounts (0.03–0.87 mg/g), and
-carotene and lycopene were only found in vestigial levels
(< 0.01 mg/g). Wild species revealed a higher content in phenols,
but a lower content in ascorbic acid than commercial mushrooms.3.3. Antimicrobial activity
Table 6 shows the antimicrobial screening of mushroom
extracts against B. cereus, B. subtilis, S. aureus (Gram +), E. coli,
P. aeruginosa, K. peumoniae (Gram –) bacteria, and C. albicans and
C. neoformans (fungi). A. silvaticus, C. cornucopioides, M. oreades
and C. gambosa did not revealed antimicrobial properties, at the
tested concentrations; the other species showed antimicrobial
activity selectively against Gram + bacteria, with very low MICs.
Table 5
Total bioactive compounds of wild and commercial mushrooms (mean ± SD; n = 3)
Phenols (mg/g) Flavonoids (mg/g) Ascorbic acid (mg/g) b-carotene (lg/g) Lycopene (lg/g)
Agaricus bisporusa 4.49 ± 0.16 d 1.73 ± 0.11 d 0.03 ± 0.00 c 1.95 ± 0.10 g 0.91 ± 0.06 eb
Agaricus silvaticusa 8.94 ± 0.44 a 3.40 ± 0.01 a 0.04 ± 0.00 c 5.42 ± 0.10 d 2.63 ± 0.06 c
Agaricus silvicolaa 6.18 ± 0.44 b 2.87 ± 0.12 b 0.04 ± 0.00 c 3.02 ± 0.12 e 2.63 ± 0.06 d
Boletus edulis 5.03 ± 0.11 c 1.75 ± 0.13 d nd 2.73 ± 0.32 fe 1.14 ± 0.08 b
Calocybe gambosa 1.70 ± 0.10 g 1.18 ± 0.16 e 0.40 ± 0.01 b 6.41 ± 1.27 c 3.30 ± 0.88 b
Cantharellus cibarius 0.88 ± 0.09 h 0.67 ± 0.11 f 0.86 ± 0.01 a 13.56 ± 0.51 a 5.06 ± 0.33 a
Craterellus cornucopioides 2.13 ± 0.38 f 1.71 ± 0.29 d 0.87 ± 0.02 a 12.77 ± 0.19 b 5.13 ± 0.14 a
Marasmius oreades 3.20 ± 0.30 e 2.26 ± 0.18 c nd 1.99 ± 0.14 fg 0.54 ± 0.08 e
In each column different letters mean signiﬁcant differences (p < 0.05).
nd – not detected.
a Barros et al., accepted for publication.
Table 6
Antimicrobial activity of wild and commercial mushrooms (mean ± SD; n = 3)
Samples MIC (lg/mL)
B. cereus B. subtilis S. aureus P. aeruginosa E. coli K. peumoniae C. albicans C. neoformans
Agaricus bisporus 500 () 5 (++++) 500 () 500 () 500 () 500 () 500 () 500 ()
Agaricus silvaticus 500 () 500 () 500 () 500 () 500 () 500 () 500 () 500 ()
Agaricus silvicola 5 (++++) 50 (++++) 5 (++++) 500 () 500 () 500 () 500 () 500 ()
Boletus edulis 500 () 500 () 5 (++++) 500 () 500 () 500 () 500 () 500 ()
Calocybe gambosa 500 () 500 () 500 () 500 () 500 () 500 () 500 () 500 ()
Cantharellus cibarius 500 () 5 (++++) 50 (++++) 500 () 500 () 500 () 500 () 500 ()
Craterellus cornucopioides 500 () 500 () 500 () 500 () 500 () 500 () 500 () 500 ()
Marasmius oreades 500 () 500 () 500 () 500 () 500 () 500 () 500 () 500 ()
Ampicillin 3.13 (++++) 12.5 (++++) 6.25 (++++) 6.25 (++++) 6.25 (++++) 6.25 (++++) NT NT
Cycloheximide NT NT NT NT NT NT 12.5 (++) 6.25 (++++)
No antimicrobial activity at the higher tested concentration (), inhibition zone <1 mm. Slight antimicrobial activity (+), inhibition zone 2–3 mm. Moderate antimicrobial
activity (++), inhibition zone 4–5 mm. High antimicrobial activity (+++), inhibition zone 6–9 mm. Strong antimicrobial activity (++++), inhibition zone >9 mm. Standard
deviation ± 0.5 mm. NT – not tested.
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even lower than the standard ampicillin. Likewise, B. edulis and A.
silvicola revealed MIC values against S. aureus lower than the stan-
dard. The antimicrobial activity was not dependent of being com-
mercial or wild mushroom, since A. bisporus and A. silvicola of the
wild sp., and B. edulis and C. cibarius of the commercial sp. showed
antimicrobial efﬁciency; it certainly depends on antimicrobials
present in each mushroom species.
4. Discussion
Among all the studied species, only the chemical composition of
A. bisporus (Manzi et al., 2001; Krbavcˇic´ and Baric´, 2004), B. edulis
(Manzi et al., 2004) and C. cibarius (Agahar-Murugkar and Sub-
bulakshmi, 2005) was described previously but from different
countries. Similar to our samples, the Indian C. cibarius contained
protein as the principal macronutrient, while in the Italian B. edulis,
carbohydrates dominated. The Italian A. bisporus sample contained
higher levels of carbohydrate than proteins, while the opposite was
observed in the Portuguese sample. Generally, high protein and
carbohydrate contents, and low fat levels were also described by
previous authors (Diéz and Alvarez, 2001). Nevertheless, the differ-
ences between the nutrient concentrations of Portuguese and In-
dian C. cibarius samples and between the Portuguese and Italian
B. edulis and A. bisporus may be attributed to a number of factors,
such as mushroom strain/type, composition of growth media, time
of harvest, management techniques, handling conditions, and the
preparation of the substrates (Manzi et al., 2001). The wild mush-
room species proved to be less energetic than the commercial sam-
ples with a higher content of protein and a lower fat concentration.
UFA predominated over SFA in all the studied mushrooms,
which is consistent with other studies (Diéz and Alvarez, 2001).The commercial B. edulis contained the highest UFA contents and
the lowest SFA levels, leading to an increase in HDL cholesterol
and decrease in LDL cholesterol, triacylglycerol, lipid oxidation,
and LDL susceptibility to oxidation (Kanu et al., 2007). The same
species revealed the highest contents of tocopherols. Some authors
published tocopherol determination in A. bisporus from Turkey
(Elmastas et al., 2007) and B. edulis from Taiwan (Tsai et al.,
2007), but using a different methodology and presenting the re-
sults per mg of extracts. In general, the commercial mushrooms re-
vealed higher concentrations of sugars, and the wild species
contained lower values of MUFA but also higher contents of PUFA.
a-Tocopherol was detected in higher amounts in the wild species,
and c-tocopherol was not found in these mushrooms. Wild sam-
ples revealed a higher content in phenols, but a lower content in
ascorbic acid than commercial mushrooms.
There were no differences between the antimicrobial properties
of wild and commercial mushrooms. The entire extracts were used
to measure potential health beneﬁts taking advantage of the addi-
tive and synergistic effects of all the bioactive compounds present
in the extracts. Therefore, mushrooms might be used not only for
their nutritional properties but also as a source for the develop-
ment of drugs and nutraceuticals. Future studies should be done
in order to conclude the mechanism of action involved in antimi-
crobial growth inhibition; there might be other compounds,
besides those quantiﬁed in this study, which contribute to antimi-
crobial properties of the wild and commercial species. The bioac-
tive compounds present in the extracts could be structurally
related to e.g. vancomycin or bacitracin which are only effective
against Gram + bacteria.
Recently, the widely consumed Tricholoma ﬂavovirens caused
delayed rhabdomyolysis in twelve humans from France and Po-
land, and also in mice after administration of consecutive meals
L. Barros et al. / Food and Chemical Toxicology 46 (2008) 2742–2747 2747of extracts of this mushroom (Bedry et al., 2001). The investigation
was extended, ﬁrst to B. edulis (Nieminen et al., 2005) and then to
other species such as C. cibarius, Russula spp., Leccinum versipelle,
Albatrellus ovinus, (Nieminen et al., 2006). The results indicated ele-
vations in the plasma creatine kinase activities and additional ef-
fects on the liver transaminases and plasma creatinine in
experimental mice. There has also been a concern about the safety
of A. bisporus, an extensively consumed mushroom worldwide.
Some authors demonstrated that lifetime administration of un-
cooked A. bisporus to mice induced tumours at a number of sites.
However, when air-dried mushroom were fed to rats for 500 days,
no carcinogenic effect was evident (Walton et al., 1998). Other
authors suggested that diets high in A. bisporus may modulate
the aromatase activity and function in chemoprevention in post-
menopausal women by reducing the in situ production of estrogen
(Grube et al., 2001). However, these ﬁndings should be interpreted
carefully since these wild mushrooms have been considered safe
for millennia. The harmful effects require prolonged daily exposure
and high amounts of ingested mushroom (Nieminen et al., 2005).
The analyzed mushrooms contain very useful nutraceuticals
such as UFA, phenolics, tocopherols, ascorbic acid, and carotenoids
which could be extracted for the purpose of being used as func-
tional ingredients namely against microbial infections. Public
health authorities consider prevention and treatment with nutra-
ceuticals a powerful instrument in maintaining and promoting
health, longevity and life quality. The beneﬁcial effects of nutraceu-
ticals will undoubtedly have an impact on nutritional therapy;
they also represent a growing segment of today’s food industry. Be-
sides, these mushrooms might be used directly in diet and promote
health, taking advantage of the additive and synergistic effects of
all the bioactive compounds present.
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